AVAI BIO, INC. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ba1f9f76-1399-4e16-a753-44f292d2dcbb/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-1.7M | 2025-04-01 – 2026-03-31 | evidence 0001740797-26-000017 |
| FY 2024 | $-1.1M | 2024-04-01 – 2025-03-31 | evidence 0001740797-25-000038 |
| FY 2023 | $-2.1M | 2023-04-01 – 2024-03-31 | evidence 0001740797-24-000031 |
| FY 2022 | $-348.9k | 2022-04-01 – 2023-03-31 | evidence 0001740797-24-000031 |
| FY 2021 | $126.5k | 2021-04-01 – 2022-03-31 | evidence 0001740797-22-000007 |
| FY 2020 | $302.3k | 2020-04-01 – 2021-03-31 | evidence 0001740797-21-000020 |
| FY 2019 | $69.6k | 2019-04-01 – 2020-03-31 | evidence 0001740797-21-000014 |
| FY 2018 | $-78.2k | 2018-04-08 – 2019-03-31 | evidence 0001740797-20-000018 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).